Gilead Sciences, Inc. (GILD)
146.34
+0.66
(+0.45%)
USD |
NASDAQ |
Aug 31, 16:00
146.02
-0.32
(-0.22%)
After-Hours: 04:52
Gilead Sciences Total Long Term Debt (Quarterly) : 26.25B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.25B |
| March 31, 2026 | 22.17B |
| December 31, 2025 | 25.44B |
| September 30, 2025 | 24.94B |
| June 30, 2025 | 24.95B |
| March 31, 2025 | 24.95B |
| December 31, 2024 | 27.21B |
| September 30, 2024 | 23.25B |
| June 30, 2024 | 23.35B |
| March 31, 2024 | 25.19B |
| December 31, 2023 | 25.53B |
| September 30, 2023 | 24.98B |
| June 30, 2023 | 25.25B |
| March 31, 2023 | 25.24B |
| December 31, 2022 | 25.23B |
| September 30, 2022 | 25.22B |
| June 30, 2022 | 26.22B |
| March 31, 2022 | 26.21B |
| December 31, 2021 | 27.18B |
| September 30, 2021 | 27.69B |
| June 30, 2021 | 30.18B |
| March 31, 2021 | 30.17B |
| December 31, 2020 | 32.01B |
| September 30, 2020 | 29.29B |
| June 30, 2020 | 24.10B |
| Date | Value |
|---|---|
| March 31, 2020 | 24.10B |
| December 31, 2019 | 25.22B |
| September 30, 2019 | 25.21B |
| June 30, 2019 | 26.56B |
| March 31, 2019 | 27.01B |
| December 31, 2018 | 27.32B |
| September 30, 2018 | 27.32B |
| June 30, 2018 | 29.06B |
| March 31, 2018 | 29.05B |
| December 31, 2017 | 33.54B |
| September 30, 2017 | 29.26B |
| June 30, 2017 | 26.30B |
| March 31, 2017 | 26.32B |
| December 31, 2016 | 26.35B |
| September 30, 2016 | 27.07B |
| June 30, 2016 | 22.13B |
| March 31, 2016 | 22.82B |
| December 31, 2015 | 22.06B |
| September 30, 2015 | 22.23B |
| June 30, 2015 | 12.28B |
| March 31, 2015 | 12.37B |
| December 31, 2014 | 12.42B |
| September 30, 2014 | 9.438B |
| June 30, 2014 | 9.540B |
| March 31, 2014 | 9.850B |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.978B |
| AbbVie, Inc. | 70.82B |
| Regeneron Pharmaceuticals, Inc. | 2.707B |
| Amgen, Inc. | 57.30B |
| Biogen, Inc. | 8.355B |